NCT03965689 2026-04-13Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyNational Cancer Institute (NCI)Phase 2 Active not recruiting27 enrolled 13 charts